申请人:Adir et Compagnie
公开号:US05254548A1
公开(公告)日:1993-10-19
A compound having an aryltriazine structure selected from those of formula (I): ##STR1## for which the meaning of the substituents Ar, R.sub.1, R.sub.5, R.sub.6, and R.sub.6 ' is given in the description. The compound of the invention is useful as medicinal product for disorders associated with a cholinergic dysfunction.
一种具有芳基三嗪结构的化合物,从以下式(I)中选择:##STR1## 其中取代基Ar,R.sub.1,R.sub.5,R.sub.6和R.sub.6 '的含义在描述中给出。该发明的化合物可用作与胆碱能功能障碍相关的药物产品。